The results showed that compared with SOC, FMT could significantly reduce the levels of ALT, AST, and PDFF in MASLD patients, but the improvement in BMI did not reach statistical significance.
← all excerpts
Meta-analysis of the effectiveness of fecal microbiota transplantation in the treatment of metabolic-associated fatty liver disease: A systematic review based on liver inflammation indicators and fat content.
1
—
—